Showing results (31-40 of 83) with videos related to
Sort By:
Pageof 9
Hematology Reports|March 14, 2017
Impact of CRAB Symptoms in Survival of Patients with Symptomatic Myeloma in Novel Agent EraAya Nakaya, Shinya Fujita, Atsushi Satake, et al.Acta Haematologica|July 21, 2017
Realistic Lenalidomide Dose Adjustment Strategy for Transplant-Ineligible Elderly Patients with Relapsed/Refractory Multiple Myeloma: Japanese Real-World ExperienceAya Nakaya, Shinya Fujita, Atsushi Satake, et al.Molecular and Clinical Oncology|February 20, 2016
Mogamulizumab treatment of refractory peripheral T-cell lymphoma following autologous stem cell transplantation: A case reportYukie Fujita, Aya Nakaya, Shinya Fujita, et al.Clinical Case Reports|December 12, 2017
Tyrosine kinase inhibitor and rituximab-CHOP treatment for concurrent chronic myeloid leukemia and non-Hodgkin lymphoma: a case reportYuki Takeyasu, Atsushi Satake, Yoshiko Azuma, et al.International Journal of Hematology|August 31, 2016
Successful treatment with mogamulizumab followed by allogeneic hematopoietic stem-cell transplantation in adult T-cell leukemia/lymphoma: a report of two casesYukie Tsubokura, Atsushi Satake, Masaaki Hotta, et al.Leukemia Research|September 26, 2016
Delayed HBV reactivation in rituximab-containing chemotherapy: How long should we continue anti-virus prophylaxis or monitoring HBV-DNA?Aya Nakaya, Shinya Fujita, Atsushi Satake, et al.[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|May 13, 2026
[Fibrin-associated large B-cell lymphoma confined to a left atrial myxoma showing durable remission after surgical resection alone]Natsumi Sakai, Masaaki Hotta, Sumire Inoue, et al.Leukemia Research Reports|August 5, 2016
Enhanced international prognostic index in Japanese patients with diffuse large B-cell lymphomaAya Nakaya, Shinya Fujita, Atsushi Satake, et al.International Journal of Cardiovascular Interventions|March 8, 2003
Biodegradable stents as a platform to drug loadingTakafumi Tsuji, Hideo Tamai, Keiji Igaki, et al.International Medical Case Reports Journal|June 12, 2013
Therapeutic effect of bortezomib for primary plasma cell leukemia followed by auto/allo stem cell transplantationRyotaro Ozasa, Masaaki Hotta, Hideaki Yoshimura, et al.Pageof 9